Expanded Program On Immunization

Expanded Program on Immunization

Background and Definition

Expanded Program on Immunization (EPI), established in 1987, aimes at guaranteeing the right of every child in Lebanon, regardless of social status or parent's education level, on immunization and protection from diseases that have available effective and safe vaccines. In order to ensure that, the Ministry of Public Health guarantees the provision of vaccines in 700 health care centers, public and social, in collaboration with the private sector and with the conitnuous awareness of care givers about the importance of immunization. The program provides further special attention to chidlren residing in remote and underprivileged areas through quality outreach activities.

EPI ِAims at:

Elevating routine vaccination coverage per district to above 95%.
Preserving Lebanon as polio-free, considering the continuous influx of Syrian refugees and in preparation to the eradication of polio in the region and worldwide.
Eradicating Measles and Rubella by the end of year 2018.

EPI Activities:

Continuous training and capacity building throughout the year for health care workers on routine vaccination management and implementation in all districs.
Continuous work to keep Lebanon certified polio-free
Implementation of the RED STRATEGY to reach every child, which includes:
1. Data on the immunization coverage for children under one year of age
2. Data on immunization coverage in Lebanon
3. Identification of the number of drop-outs and planning to ensure their vaccination per district accordingly
Celebrating World Immunization Week and planning awareness sessions over Lebanon about routine vaccination
Conducting National and Mop-Up Immunization campaigns annually, including vaccination against Measles, Rubella, and Mumps
Conducting regular visits by the self-assessment team to follow on the quality of vaccination delivery service
Continuous collaboration with UNICEFand WHO to follow-up on updates related to immunization worldwide and ensuring implementation in Lebanon considering national and international commitments
Continuous collaboration with the private sector (General Practictioners and Pediatricians) to ensure vaccination for all children in Lebanon, particularly during immunization campaigns and routine immunization.

...

120

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D07AC13	ELISONE	G	Mometasone furoate - 0.1%	0.1%	Cream	435,405 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Cream	335,321 L.L
D07AC13	XEMADERM	G	Mometasone furoate - 0.1%	0.1%	Cream	335,961 L.L
D07AC13	ELICA	G	Mometasone furoate micronized - 1mg/g	0.1%	Ointment	399,121 L.L
D07AC13	ELOCOM	B	Mometasone furoate - 1mg/g	0.1%	Lotion	282,207 L.L
D07AC13	KONEX	G	Mometasone furoate - 0.1%	0.1%	Solution	385,683 L.L
D07AC13	METASONE	G	Mometasone furoate - 0.1%	0.1%	Lotion	239,332 L.L
D07AC04	FLUOCINOLONE ACETONIDE	G	Fluocinolone acetonide - 0.25mg/g	0.25mg/g	Cream	296,925 L.L
D07AC01	DIPROSONE	B	Betamethasone (dipropionate) - 0.5mg/g	0.05%	Cream	291,614 L.L
D07AC01	BETNOVATE	B	Betamethasone (valerate) - 0.1%	0.1% w/w	Ointment	279,519 L.L
D07AC01	BETNOVATE	B	Betamethasone - 0.1%	0.1%	Solution	235,172 L.L
D07AC01	BETNOVATE	B	Betamethasone (valerate) - 0.1%	0.1% w/w	Cream	279,519 L.L
D07AC01	BETASONE	G	Betamethasone (valerate) - 1mg/g	1mg/g	Cream	120,306 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 1mg/g	0.1%	Cream	215,015 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lipocream	221,734 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lipocream	221,734 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
D07AB02	LOCOID CRELO 0.1%	B	Hydrocortisone butyrate - 1mg/g	0.1%	Emulsion	177,387 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lotion	201,576 L.L
D07AB02	LOCOID	B	Hydrocortisone butyrate - 0.1%	0.1%	Lotion	201,576 L.L
D07AA02	HYDROCORTISONE ACETATE	G	Hydrocortisone acetate - 1%	1%	Cream	215,015 L.L
D06BX01	ROZEX	B	Metronidazole - 0.75g/100g	0.75%	Gel	584,571 L.L
D06BX01	CUTIDERMINE	G	Metronidazole - 1%	1%	Gel	593,850 L.L
D06BB53	ACTI-VIR H	G	Aciclovir - 5%, Hydrocortisone acetate - 1%		Cream	833,182 L.L
D06BB10	ALDARA	B	Imiquimod - 5%	5%	Cream	6,301,277 L.L
D06BB10	GENIMOD	G	Imiquimod - 5%	5%	Cream	2,268,406 L.L
D06BB10	JEDARA	G	Imiquimod - 5%	5%	Cream	3,850,109 L.L
D06BB03	CIVAR	G	Aciclovir - 5%	5%	Cream	507,972 L.L
D06BB03	CYCLOVEX	G	Aciclovir - 50mg/g	50mg/g	Cream	345,560 L.L

...

120

...